UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Precision Medicine in Cancer Therapy

1, 2019

Volltextzugriff (PDF)

Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look

Cancer discovery, 2011-09, Vol.1 (4), p.291-296

2011

Volltextzugriff (PDF)

Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review

World journal of gastrointestinal oncology, 2015-09, Vol.7 (9), p.132-140

2015

Volltextzugriff (PDF)

Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations

Cancer discovery, 2014-08, Vol.4 (8), p.905-913

2014

Volltextzugriff (PDF)

Phase 1 Clinical Trials in the Elderly: Enrollment Challenges

Journal of the advanced practitioner in oncology, 2020-07, Vol.11 (5), p.494-501

2020

Volltextzugriff (PDF)

Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors

Cancer discovery, 2017-07, Vol.7 (7), p.704-715

2017

Volltextzugriff (PDF)

Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases

Oncotarget, 2014-12, Vol.5 (23), p.12440-12447

2014

Volltextzugriff (PDF)

CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin binding

Oncotarget, 2017-09, Vol.8 (43), p.74006-74018

2017

Volltextzugriff (PDF)

Botensilimab, an Fc-enhanced anti-CTLA-4 antibody, is effective against tumors poorly responsive to conventional immunotherapy

Cancer discovery, 2024-07

2024

Volltextzugriff (PDF)

An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma

Oncotarget, 2020-05, Vol.11 (21), p.1929-1941

2020

Volltextzugriff (PDF)

Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial

Journal of gastrointestinal oncology, 2016-06, Vol.7 (3), p.469-478

2016

Volltextzugriff (PDF)

A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients

Journal of gastrointestinal oncology, 2017-12, Vol.8 (6), p.925-935

2017

Volltextzugriff (PDF)

New drugs for patients with pancreatic cancer

Current opinion in oncology, 2002-11, Vol.14 (6), p.621-627

2002

Volltextzugriff (PDF)

Basal cell nevus syndrome: a brave new world

Archives of dermatology (1960), 2010-01, Vol.146 (1), p.17

2010

Volltextzugriff (PDF)

“Cytolytic Immune Lymphocytes,” by Joseph G. Sinkovics, MD

Oncology times, 2010-03, Vol.32 (5), p.48-49

2010

Volltextzugriff (PDF)

Topoisomerase I-DNA complex stability induced by camptothecins and its role in drug activity

Current medicinal chemistry. Anti-cancer agents, 2004-07, Vol.4 (4), p.327-334

2004

Volltextzugriff (PDF)

Acute cutaneous reactions to docetaxel, a new chemotherapeutic agent

Archives of dermatology (1960), 1995-02, Vol.131 (2), p.202

1995

Volltextzugriff (PDF)

Whole Exome Sequencing of Primary Cardiac Angiosarcoma Highlights Potential for Targeted Therapies

Case Reports in Cardiology, 2024, p.113-128

1, 2024

Volltextzugriff (PDF)